Kush Parmar - Nov 14, 2025 Form 4 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Signature
/s/ Kush Parmar
Stock symbol
TRDA
Transactions as of
Nov 14, 2025
Transactions value $
-$1,760,000
Form type
4
Date filed
11/18/2025, 04:36 PM
Previous filing
Jul 11, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PARMAR KUSH Director, 10%+ Owner C/O 5AM VENTURE MANAGEMENT, LLC, 4 EMBARCADERO CENTER, SUITE 3110, SAN FRANCISCO /s/ Kush Parmar 2025-11-18 0001664281

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRDA Common Stock Sale -$1.76M -200K -6.32% $8.80 2.96M Nov 14, 2025 By 5AM Ventures V, L.P. F1, F2
holding TRDA Common Stock 1.09M Nov 14, 2025 By 5AM Opportunities I, L.P. F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.80 to $9.023 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 Shares are held by 5AM Ventures V, L.P. ("5AM V"). 5AM Partners V, LLC ("5AM Partners") is the sole general partner of 5AM V. Kush M. Parmar, M.D., Ph.D. is a managing member of 5AM Partners and may be deemed to share voting and investment power over the shares held by 5AM V. Dr. Parmar disclaims beneficial ownership of the shares held by 5AM V except to the extent of his pecuniary interest therein.
F3 Shares are held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Kush M. Parmar, M.D., Ph.D. is a managing member of Opportunities GP and may be deemed to share voting and investment power over the shares held by Opportunities. Dr. Parmar disclaims beneficial ownership of the shares held by Opportunities except to the extent of his pecuniary interest therein.